Royalty Pharma plc (NASDAQ:RPRX) Q3 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma Third Quarter 2023 Earnings Conference Call.
Repros Therapeutics Inc. (RPRX)
Market is closed
News
- First
- << Previous
- 21 - 30
- Next >>
10 Blue-Chip Stocks at All-Time Lows
The inflation storm and subsequent rate hikes by the Federal Reserve have left investors on the back foot as a strange skepticism has taken over the market.
10 Biotech Stocks with Biggest Upside
In this article, we discuss 12 biotech stocks with biggest upside.
Royalty Pharma plc (NASDAQ:RPRX) Q2 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma second quarter earnings conference call.
15 Worst Performing Biotech Stocks in 2023
In this article, we discuss 15 worst performing biotech stocks in 2023.
Insider Buying Alert: These 10 Stocks are Seeing Significant Insider Activity
In this article, we will take a look at the 10 stocks that are seeing significant buy-side insider activity.
Hedge Fund and Insider Trading News: Michael Burry, Ken Griffin, Bridgewater Associates, Great Elm Group Inc (GEG), Luminar Technologies, Inc. (LAZR), and More
Michael Burry predicted the subprime mortgage crisis that preceded one of the worst market crashes in history, and he recently took a large position in this growth stock.
15 Stocks Warren Buffett Sold
Berkshire Hathaway, headed by Warren Buffett, sold $13.3 billion worth of stock in the first quarter of 2023 while investing only a fraction of that amount in US equities.
10 Large-Cap Stocks with Insider Buying
On May 12 Katie Stockton, founder and managing partner of Fairlead Strategies, appeared in an interview on CNBC to discuss current market trends and her outlook for the back half of 2023.
- First
- << Previous
- 21 - 30
- Next >>
Billionaire Hedge Funds
